Format

Send to

Choose Destination
Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Dec 6;51(12):1121-1123. doi: 10.3760/cma.j.issn.0253-9624.2017.12.014.

[Safety evaluation of 10 μg recombinant hepatitis B vaccine (saccharomyces cerecisiae yeast) based on the results of a phase of Ⅳ clinical trial].

[Article in Chinese]

Author information

1
Shenzhen Kangtai Biological Products CO., LTD., Shenzhen 518057, China.

KEYWORDS:

Adverse reactions; Clinical trial; Hepatitis B vaccines; Infant, newborn

Supplemental Content

Full text links

Icon for Chinese Medical Association Publishing House Ltd.
Loading ...
Support Center